Venaxis reports plans to price a public offering of its common stock

Piper Jaffray assists in raising funds for general corporate purposes

By Devika Patel

Knoxville, Tenn., May 9 - Venaxis, Inc. will price a public sale of common stock with a 30-day greenshoe option, according to a Form S-1 filed Thursday with the Securities and Exchange Commission.

Piper Jaffray is assisting.

Proceeds will be used for general corporate purposes.

The biomedical diagnostic company is based in Castle Rock, Colo.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.